skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures


(Last updated: September 1, 2014; last reviewed: September 1, 2014)

Mycobacterium tuberculosis Infection and Disease
Member Financial Disclosure
Company Relationship
Dooley, Kelly Johns Hopkins University Viiv Health Care Research Support
Gandhi, Neel Rollins School of Public Health-Emory University None N/A
Havlir, Diane* University of California, San Francisco Abbot Research Support
Gilead Research Support
Luetkemeyer, Annie University of California, San Francisco Cepheid Research Support
Maartens, Gary University of Cape Town, South Africa None N/A
Meintjes, Graeme
University of Cape Town, South Africa Sanofi-Aventis Speaker's Bureau
Shah, Sarita Centers for Disease Control and Prevention None N/A
Sterling, Timothy Vanderbilt University Otsuka DSMB Member
Sanofi Consultant

* Group lead

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from September 1, 2012, through September 1, 2014.

Back to Top